All In Biotech

Free tool

FAERS Monitor: Ultra-Technekow V4

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 017243 or its brand name (Ultra-Technekow V4, Technetium Tc-99m Sodium Pertechnetate Generator). Reports on generic versions are filed under their own applications.

Reports

628

Serious

84

13% of reports

Hospitalization

29

Death reported

11

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective271
  • no adverse event209
  • radioisotope scan abnormal158
  • scan myocardial perfusion abnormal24
  • nausea18
  • headache16
  • radiation overdose16
  • rash15
  • urticaria15
  • pruritus14
  • vomiting14
  • product quality issue13
  • pyrexia10
  • diarrhoea9
  • dizziness9

Reports by year received

View as table
YearReports
20061
200710
200830
2009112
201087
201140
20127
20162
20172
20183
201910
202015
202130
202247
202325
202430
202573
2026104

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,531 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
radiation overdoseSignal1614115.77912.4149,132
radioisotope scan abnormalSignal1589648.38232.21,176,065
scan myocardial perfusion abnormalSignal246189.24032.7120,182
no adverse eventSignal20938.734.67,691
drug ineffectiveSignal2716.96.31,449
product quality issueSignal133.21.918
urticariaSignal153.01.818
pruritus141.20.70
rash151.20.70
vomiting141.00.60
pyrexia101.00.50
headache160.90.50
nausea180.80.51
dizziness90.60.32
diarrhoea90.50.25

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.